Medicare has proposed limiting coverage of Aduhelm, a costly new drug to treat Alzheimer’s disease, and prominent groups are pressing to make it more available. But among those facing the disease, the outlook is nuanced.
from Section Page News - Modern Healthcare https://ift.tt/xKdsYNX